Get the Stockscreener App
11.53
12.27%
1.26
After Hours:
11.45
-0.08
-0.69%
Tempest Therapeutics Inc stock is traded at $11.53, with a volume of 77,675.
It is up +12.27% in the last 24 hours and up +12.43% over the past month.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.
See More
Previous Close:
$10.27
Open:
$10.26
24h Volume:
77,675
Relative Volume:
1.10
Market Cap:
$51.20M
Revenue:
-
Net Income/Loss:
$-43.10M
P/E Ratio:
-1.1861
EPS:
-9.7212
Net Cash Flow:
$-36.82M
1W Performance:
+6.37%
1M Performance:
+12.43%
6M Performance:
+85.37%
1Y Performance:
-13.47%
1-Day Range:
$10.26
$11.58
1-Week Range:
$10.21
$11.58
52-Week Range:
$5.3495
$20.67
Tempest Therapeutics Inc Stock (TPST) Company Profile
Name
Tempest Therapeutics Inc
Sector
Industry
Phone
415-798-8589
Address
2000 SIERRA POINT PARKWAY, BRISBANE
Compare TPST with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TPST
Tempest Therapeutics Inc
|
11.53 | 45.60M | 0 | -43.10M | -36.82M | -9.7212 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
557.73 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
799.56 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
327.03 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Tempest Therapeutics Inc Stock (TPST) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-10-25 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Apr-10-25 | Downgrade | Scotiabank | Sector Outperform → Sector Perform |
| Mar-14-24 | Initiated | Scotiabank | Sector Outperform |
| Feb-08-24 | Initiated | Jefferies | Buy |
Tempest Therapeutics Inc Stock (TPST) Latest News
What’s next for Tempest Therapeutics Inc. stock priceJuly 2025 Chart Watch & High Accuracy Investment Entry Signals - newser.com
Can Tempest Therapeutics Inc. stock maintain growth trajectoryTreasury Yields & Advanced Swing Trade Entry Alerts - newser.com
Is Tempest Therapeutics Inc. stock cheap at current valuationTrade Signal Summary & Real-Time Stock Price Movement Reports - newser.com
Will Tempest Therapeutics Inc. stock recover after recent dropPortfolio Update Summary & Free Weekly Watchlist of Top Performers - newser.com
How Tempest Therapeutics Inc. stock performs in interest rate cyclesMarket Performance Recap & Long-Term Safe Return Strategies - newser.com
How to use Fibonacci retracement on Tempest Therapeutics Inc.Weekly Stock Report & Step-by-Step Swing Trade Plans - newser.com
Tempest Therapeutics (NASDAQ:TPST) Upgraded at Wall Street Zen - Defense World
Is it time to cut losses on Tempest Therapeutics Inc.Weekly Stock Analysis & Community Verified Trade Signals - newser.com
Is Tempest Therapeutics Inc. stock reversal real or fakeQuarterly Portfolio Report & Technical Confirmation Alerts - newser.com
How Tempest Therapeutics Inc. stock benefits from global expansion2025 Big Picture & Daily Stock Trend Watchlist - newser.com
Technical signs of recovery in Tempest Therapeutics Inc.July 2025 Levels & Expert Verified Movement Alerts - newser.com
Is Tempest Therapeutics Inc. still worth holding after the dipJuly 2025 Trade Ideas & Safe Swing Trade Setup Alerts - newser.com
What moving averages say about Tempest Therapeutics Inc.Dollar Strength & High Yield Equity Trading Tips - newser.com
Should you wait for a breakout in Tempest Therapeutics Inc.Market Movers & Community Driven Trade Alerts - newser.com
Is Tempest Therapeutics Inc a good long term investmentGlobal Market Influence & Ride the Wave of Market-Beating Growth - earlytimes.in
Real time social sentiment graph for Tempest Therapeutics Inc.Weekly Gains Summary & High Win Rate Trade Alerts - newser.com
Applying chart zones and confluence areas to Tempest Therapeutics Inc.July 2025 Levels & Weekly Momentum Stock Picks - newser.com
Tempest Therapeutics Inc Stock (TPST) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):